FDA Grants Tentative Approval to Amneal Pharmaceuticals' Generic Version of QVAR Inhalation Aerosol
Beclomethasone dipropionate HFA inhalation aerosol is a corticosteroid indicated for the maintenance treatment of asthma as a prophylactic therapy in patients aged five years and older. It is not indicated for the relief of acute bronchospasm.
FDA Grants Pharma | 31/10/2025 | By Darshana | 118
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy